Investors

Presentations & Reports

2020

For investor-related information please contact Ronn Bechler at Automic Group
Ph: +61 (0) 400 009 774 E: ronn.bechler@automicgroup.com.au

2023

Zelira Half Yearly Report FY22/23

March 1, 2023

https://www.youtube.com/watch?v=e70YU5MorQw

Investor Webinar: HOPE^® 1 SPV created to fund Ph.2 and Ph.3 US FDA trials

Chairman Osagie Imasogie and CEO Oludare Odumosu lead a presentation on the creation of an SPV and US $8.6M cornerstone funding from Cantheon Capital LLC for HOPE 1 Ph.2 and Ph.3 US FDA clinical trials.

February 22, 2023

2022

Hannam and Partners Investor Report – Zelira completes enrolment in Diabetic Nerve Pain trial

H&P’s updated report on Zelira highlighted by the completed enrolment of participants in the diabetic nerve pain trial

November 24, 2022

https://www.youtube.com/watch?v=d2JWfoye_88

Zelira AGM Presentation 2022

Zelira Therapeutics Chairman Osagie Imasogie and Global CEO Oludare Odumosu present a company update at the 2022 Annual General Meeting.

November 17, 2022

https://www.youtube.com/watch?v=fsl485JesLA

Zelira CEO Oludare Odumosu speaks with Proactive

Zelira Global CEO Oludare Odumosu provides Proactive with an update on the company’s progress with its proprietary revenue-generating products, global expansion and its pipeline of candidates undergoing clinical development.

November 15, 2022

2021

https://zeliratx.com/presentations/Proactiveinvestors_AU_-_Zelira_Therapeutics_commercialisation_program_to_see_launch_of_suite_of_new_cannabinoid-based_prod.pdf

Zelira Therapeutics’ commercialisation program

Zelira to launch a suite of new cannabinoid-based products in FY22 – Proactive

September 1, 2021

https://www.youtube.com/watch?v=muhK--qz0hY

Channel 9 News Perth

Zelira Therapeutics and Curtin University partner on research of proprietary technology that demonstrates significant uptake of CBD into the brain

August 25, 2021

https://zeliratx.com/presentations/Zelira_Therapeutics-Cantor_Presentation-June_29_2021.pdf

Presentation at Cantor Fitzgerald International Cannabis Forum

Zelira Therapeutics Investor Slide Deck

June 29, 2021

2020

https://www.youtube.com/watch?v=to0cJZkeXNM

Proactive – Zelira Therapeutics forms exclusive licensing deal to distribute its HOPE products in Washington DC

Zelira Therapeutics forms exclusive licensing deal to distribute its HOPE products in Washington DC

December 18, 2020

https://www.youtube.com/watch?v=eipQrkRxw_0

Proactive – Zelira Therapeutics and Emyria team up for ‘disruptive’ autism spectrum disorder trial

Some excerpt

November 9, 2020

https://clients3.weblink.com.au/pdf/ZLD/02296985.pdf

Investor Presentation – Non-Deal Roadshow

October 22, 2020

2019

https://www.youtube.com/watch?v=6LZLvRG9CeM

Proactive Interview – Zelira Therapeutics on its acquisition with Ilera

December 3, 2019

https://zeliratx.com/wp-content/uploads/2019/10/CFN-Media-Interviews-Zelda-Therapeutics-at-New-West-Summit2-Mp4-Video-1280x720-5-.mp4

CFN Media Interviews Zelda Therapeutics at New West Summit

October 24, 2019

https://zeliratx.com/wp-content/uploads/2019/10/Zelda-Therapeutics-Investor-Teleconference-10002468-161019.mp3

Zelda Therapeutics – Investor Teleconference, 16 October 2019

October 16, 2019

2018

https://www.youtube.com/watch?v=W4qXsc9jeok

Zelda Therapeutics poised to ‘value add al the way from clinical trails to the market’.

December 2, 2018

https://www.youtube.com/watch?v=W4qXsc9jeok

Zelda Therapeutics poised to ‘value add all the way from clinical trails to the market’

December 2, 2018

https://zeliratx.com/presentations/Investor_Presentation_Nondeal_RoadshowNOV2018.pdf

AGM Presentation – Non-deal Roadshow

November 30, 2018

2017

https://zeliratx.com/presentations/Preso_Nov2017.pdf

AGM Presentation

November 30, 2017

https://zeliratx.com/presentations/Preso_Feb2017.pdf

Investor Presentation

February 18, 2017

2016

https://zeliratx.com/presentations/Preso_Nov2016.pdf

Investor Presentation

November 30, 2016

2015

https://zeliratx.com/presentations/Preso_Dec2015.pdf

Investor Presentation

December 1, 2015

Investors

Presentations & Reports

Presentations & Reports

2020

2023

2022

2021

2020

2019

2018

2017

2016

2015

Contact Us

Follow Zelira Therapeutics

Subscribe